View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, May 17 (HealthDay News) -- High levels of organophosphate exposure have been associated with adverse effects on neurodevelopment, and cross-sectional data suggest that levels of exposure common in U.S. children may contribute to attention-deficit/hyperactivity disorder (ADHD) prevalence, according to research published online May 17 in Pediatrics.
Maryse F. Bouchard, Ph.D., of Harvard University in Boston, and colleagues analyzed data on 1,139 children from the National Health and Nutrition Examination Survey (2000 to 2004) who were representative of the U.S. population.
The researchers found that 119 of the children met the diagnostic criteria for ADHD. Those who had higher urinary dialkyl phosphate concentrations, particularly dimethyl alkylphosphate (DMAP), had a higher likelihood of being diagnosed with ADHD; a 10-fold increase in DMAP concentration was linked to an odds ratio of 1.55 after adjusting for a number of demographic and clinical factors. Children with levels of the most commonly detected DMAP metabolite above the median level of detected concentrations had twice the odds of ADHD compared with children whose levels were undetectable.
"These findings support the hypothesis that organophosphate exposure, at levels common among U.S. children, may contribute to ADHD prevalence. Prospective studies are needed to establish whether this association is causal," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top